Innovative treatment programs against cancer: I. Ras oncoprotein as a molecular target
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 56 (11) , 1411-1426
- https://doi.org/10.1016/s0006-2952(98)00211-1
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Ras target proteins in eukaryotic cellsThe FASEB Journal, 1995
- The MAPK signaling cascadeThe FASEB Journal, 1995
- Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells.Molecular and Cellular Biology, 1994
- Mitogenic activation of the Ras guanine nucleotide exchange factor in NIH 3T3 cells involves protein tyrosine phosphorylation.Proceedings of the National Academy of Sciences, 1993
- Selective Inhibition of the Growth of ras-Transformed Human Bronchial Epithelial Cells by Emodin, a Protein-Tyrosine Kinase InhibitorBiochemical and Biophysical Research Communications, 1993
- Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factorCell, 1993
- Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signallingNature, 1993
- The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1Nature, 1993
- Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts.Proceedings of the National Academy of Sciences, 1993
- A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionCell, 1992